Clinical Trial Update: Delayed Effects of Treatment in Cancer Survivors (DETECS)

View source ↗

Summary

The DETECS clinical trial (NCT02067637) investigating delayed treatment effects in cancer survivors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gynecologic Cancer
• Leukemia
• Lymphoma

Snippet

Sponsor: University of Colorado, Denver | Conditions: Breast Cancer, Leukemia | Status: WITHDRAWN